Release from Memphis Pharmaceuticals (MPCI.CA) Concerning Amendment in the Board
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Release from the company regarding an amendment in the representatives of the company’s Board members.
The Release (269 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Release from the company regarding an amendment in the representatives of the company’s Board members.
The Release (269 KB)
Comments